Hungarian-German-Italian-Polish Joint Meeting on Medicinal Chemistry, Budapest, Hungary, 2–6 September 2001
Molecular recognition at kappa opioid receptors
Semicarbazide-sensitive amine oxidase. Its physiological significance
Chemical development of the vasopressin receptor 2 antagonist SR-121463
New developments in A1 and A2 adenosine receptor antagonists
Antitumor acridines with diaminoalkylo pharmacophoric group
NMR spectroscopy in drug design
Retinoic acid and analogs as potent inducers of differentiation and apoptosis. New promising chemopreventive and chemotherapeutic agents in oncology
New chemical structures of hypolipidemic and antiplatelet activity
New small-molecule tubulin inhibitors
Gradient HPLC in the determination of drug lipophilicity and acidity
Rational design and synthesis of homochiral azole antifungal agents
Combinatorial chemistry. Facing the challenge of chemical genomics
Opioid and sigma receptor studies. New developments in the design of selective sigma ligands